Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors.

PubWeight™: 1.91‹?› | Rank: Top 3%

🔗 View Article (PMID 17132685)

Published in Mol Pharmacol on November 28, 2006

Authors

L Tapia1, A Kuryatov, J Lindstrom

Author Affiliations

1: Departmento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Spain.

Articles citing this

Nicotine addiction. N Engl J Med (2010) 4.13

The dynamic effects of nicotine on the developing brain. Pharmacol Ther (2009) 3.01

Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet (2009) 2.35

Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR function. Mol Pharmacol (2010) 2.02

Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther (2010) 1.57

Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Br J Pharmacol (2009) 1.45

Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation. J Neurosci (2008) 1.43

Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia. Neuropsychopharmacology (2011) 1.42

Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity. J Biol Chem (2011) 1.39

Ligand Binding at the 4-4 Agonist-Binding Site of the 42 nAChR Triggers Receptor Activation through a Pre-Activated Conformational State. PLoS One (2016) 1.38

Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol Sin (2009) 1.30

Expression of functional human α6β2β3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers. Mol Pharmacol (2010) 1.28

The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy. J Neurosci (2010) 1.19

Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability. Neuropharmacology (2013) 1.18

Developmental excitation of corticothalamic neurons by nicotinic acetylcholine receptors. J Neurosci (2008) 1.15

3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors. Trends Pharmacol Sci (2008) 1.14

The nicotinic acetylcholine receptors of the parasitic nematode Ascaris suum: formation of two distinct drug targets by varying the relative expression levels of two subunits. PLoS Pathog (2009) 1.13

Human α3β4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells. PLoS One (2010) 1.09

Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochem Pharmacol (2009) 1.09

Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther (2010) 1.08

Structural determinants of Ca2+ permeability and conduction in the human 5-hydroxytryptamine type 3A receptor. J Biol Chem (2008) 1.07

Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release. Neuropharmacology (2012) 1.03

Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment. Mol Pharmacol (2009) 1.00

Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains. Ann N Y Acad Sci (2008) 0.99

NMR structures of the transmembrane domains of the α4β2 nAChR. Biochim Biophys Acta (2012) 0.97

X-ray structure of the human α4β2 nicotinic receptor. Nature (2016) 0.97

Lynx1 shifts α4β2 nicotinic receptor subunit stoichiometry by affecting assembly in the endoplasmic reticulum. J Biol Chem (2014) 0.95

Nicotinic α5 subunits drive developmental changes in the activation and morphology of prefrontal cortex layer VI neurons. Biol Psychiatry (2011) 0.94

Structural answers and persistent questions about how nicotinic receptors work. Front Biosci (2008) 0.93

Involvement of hippocampal jun-N terminal kinase pathway in the enhancement of learning and memory by nicotine. Neuropsychopharmacology (2010) 0.92

Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Hum Genet (2012) 0.92

Live-cell imaging of single receptor composition using zero-mode waveguide nanostructures. Nano Lett (2012) 0.90

Inside-out neuropharmacology of nicotinic drugs. Neuropharmacology (2015) 0.89

Förster resonance energy transfer (FRET) correlates of altered subunit stoichiometry in cys-loop receptors, exemplified by nicotinic α4β2. Int J Mol Sci (2012) 0.88

Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling. J Neurosci (2014) 0.88

Acute activation, desensitization and smoldering activation of human acetylcholine receptors. PLoS One (2013) 0.88

The α5 subunit regulates the expression and function of α4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area. PLoS One (2013) 0.86

Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors. J Biol Chem (2010) 0.86

The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization. Br J Pharmacol (2013) 0.85

Modulation of recombinant, α2*, α3* or α4*-nicotinic acetylcholine receptor (nAChR) function by nAChR β3 subunits. J Neurochem (2012) 0.85

Choline promotes nicotinic receptor alpha4 + beta2 up-regulation. J Biol Chem (2010) 0.84

nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. Schizophr Res (2016) 0.84

A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. Cancer Epidemiol Biomarkers Prev (2011) 0.84

Nicotine shifts the temporal activation of hippocampal protein kinase A and extracellular signal-regulated kinase 1/2 to enhance long-term, but not short-term, hippocampus-dependent memory. Neurobiol Learn Mem (2014) 0.83

Tracking the molecular evolution of calcium permeability in a nicotinic acetylcholine receptor. Mol Biol Evol (2014) 0.82

Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex. Cell Mol Life Sci (2014) 0.82

Potential therapeutic uses of mecamylamine and its stereoisomers. Pharmacol Biochem Behav (2013) 0.82

Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons. FASEB J (2015) 0.81

Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit. J Pharmacol Exp Ther (2015) 0.80

Quantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus. J Neurochem (2010) 0.80

Efficient expression of functional (α6β2)2β3 AChRs in Xenopus oocytes from free subunits using slightly modified α6 subunits. PLoS One (2014) 0.80

The Nicotine Metabolite, Cotinine, Alters the Assembly and Trafficking of a Subset of Nicotinic Acetylcholine Receptors. J Biol Chem (2015) 0.79

Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats. Biochem Pharmacol (2013) 0.79

Impaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's Disease. J Neurosci (2015) 0.78

Chrna5 genotype determines the long-lasting effects of developmental in vivo nicotine exposure on prefrontal attention circuitry. Neuropharmacology (2013) 0.78

The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain. Biochem Pharmacol (2015) 0.78

Pharmacological profile of Ascaris suum ACR-16, a new homomeric nicotinic acetylcholine receptor widely distributed in Ascaris tissues. Br J Pharmacol (2016) 0.78

α4β2 Nicotinic Acetylcholine Receptors: relationships between subunit stoichiometry and function at the single channel level. J Biol Chem (2016) 0.77

Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory. Physiol Behav (2015) 0.77

Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES. Eur J Pharmacol (2012) 0.77

Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy. Neuropharmacology (2015) 0.77

Regulation of α4β2α5 nicotinic acetylcholinergic receptors in rat cerebral cortex in early and late adolescence: Sex differences in response to chronic nicotine. Neuropharmacology (2015) 0.77

The prototoxin LYPD6B modulates heteromeric α3β4-containing nicotinic acetylcholine receptors, but not α7 homomers. FASEB J (2015) 0.76

Increased nicotine response in iPSC-derived human neurons carrying the CHRNA5 N398 allele. Sci Rep (2016) 0.75

Nicotinic Acetylcholine Receptors as Targets for Tobacco Cessation Therapeutics: Cutting-Edge Methodologies to Understand Receptor Assembly and Trafficking. Neuromethods (2016) 0.75

Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors. J Biol Chem (2016) 0.75

Natural genetic variability of the neuronal nicotinic acetylcholine receptor subunit genes in mice: Consequences and confounds. Neuropharmacology (2014) 0.75

Postsynaptic nicotinic acetylcholine receptors facilitate excitation of developing CA1 pyramidal neurons. J Neurophysiol (2016) 0.75

Characterizing low affinity epibatidine binding to α4β2 nicotinic acetylcholine receptors with ligand depletion and nonspecific binding. BMC Biophys (2011) 0.75

A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior. Neuropharmacology (2013) 0.75

Layer-specific cholinergic control of human and mouse cortical synaptic plasticity. Nat Commun (2016) 0.75

Approaching the 5-HT₃ receptor heterogeneity by computational studies of the transmembrane and intracellular domains. J Comput Aided Mol Des (2013) 0.75

The Distribution of Charged Amino Acid Residues and the Ca(2+) Permeability of Nicotinic Acetylcholine Receptors: A Predictive Model. Front Mol Neurosci (2017) 0.75

Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments. Psychopharmacology (Berl) (2016) 0.75

Articles by these authors

Autoimmune response to acetylcholine receptor. Science (1973) 4.59

Expression of functional acetylcholine receptor from cloned cDNAs. Nature (1984) 2.41

Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol Pharmacol (2005) 2.39

alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors. J Pharmacol Exp Ther (1998) 2.33

Appearance of acetylcholine receptors during differentiation of a myogenic cell line. Proc Natl Acad Sci U S A (1972) 2.29

An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol (1977) 2.10

Assembly in vivo of mouse muscle acetylcholine receptor: identification of an alpha subunit species that may be an assembly intermediate. Cell (1983) 2.07

Modulation of acetylcholine receptor by antibody against the receptor. Proc Natl Acad Sci U S A (1977) 2.04

Studies on purified eel acetylcholine receptor and anti-acetylcholine receptor antibody. Proc Natl Acad Sci U S A (1973) 2.02

Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res (2008) 1.98

Biochemical properties of acteylcholine receptor subunits from Torpedo californica. Biochemistry (1979) 1.94

Single-channel recordings from purified acetylcholine receptors reconstituted in bilayers formed at the tip of patch pipets. Biochemistry (1983) 1.82

Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem (1996) 1.80

Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys. J Clin Invest (1999) 1.77

Production and assay of antibodies to acetylcholine receptors. Methods Enzymol (1981) 1.73

Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron (1990) 1.72

Inhibition of glycosylation with tunicamycin blocks assembly of newly synthesized acetylcholine receptor subunits in muscle cells. J Biol Chem (1982) 1.72

Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol (1994) 1.68

Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc Natl Acad Sci U S A (1987) 1.62

Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J Neurochem (2007) 1.60

Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J Biol Chem (1991) 1.57

Effect of fibroblast growth factor on the division and fusion of bovine myoblasts. J Cell Biol (1976) 1.52

Autoimmune response to acetylcholine receptors in myasthenia gravis and its animal model. Adv Immunol (1979) 1.51

Reconstitution of purified acetylcholine receptors with functional ion channels in planar lipid bilayers. Proc Natl Acad Sci U S A (1980) 1.50

Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses. Neuropharmacology (2000) 1.49

Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol (1995) 1.49

Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor. FEBS Lett (1983) 1.49

Purification of acetylcholine receptors, reconstitution into lipid vesicles, and study of agonist-induced cation channel regulation. J Biol Chem (1980) 1.48

Evidence for unpredicted transmembrane domains in acetylcholine receptor subunits. Proc Natl Acad Sci U S A (1985) 1.45

Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells. J Biol Chem (1998) 1.45

Anti-acetylcholine receptor antibody in neonatal myasthenia gravis. N Engl J Med (1977) 1.44

Expression of acetylcholine receptor alpha-subunit mRNA during differentiation of the BC3H1 muscle cell line. J Biol Chem (1984) 1.43

Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol Pharmacol (1994) 1.39

Formation of the alpha-bungarotoxin binding site and assembly of the nicotinic acetylcholine receptor subunits occur in the endoplasmic reticulum. J Biol Chem (1987) 1.39

Immunological studies of acetylcholine receptors. J Supramol Struct (1976) 1.38

Photo-affinity labeling of specific acetylcholine-binding sites on membranes. Proc Natl Acad Sci U S A (1970) 1.38

Regulation of surface expression of acetylcholine receptors in response to serum and cell growth in the BC3H1 muscle cell line. J Biol Chem (1983) 1.36

Location of subunits within the acetylcholine receptor by electron image analysis of tubular crystals from Torpedo marmorata. J Cell Biol (1987) 1.34

Specificities of antibodies to acetylcholine receptors. Muscle Nerve (1979) 1.34

Transmembrane topography of nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydrophobicity profiles. Biochemistry (1986) 1.33

Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J Neurosci (1997) 1.32

Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J Neuroimmunol (1987) 1.31

Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J Comp Neurol (1994) 1.30

Chronic nicotine exposure differentially affects the function of human alpha3, alpha4, and alpha7 neuronal nicotinic receptor subtypes. J Pharmacol Exp Ther (1997) 1.29

Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle. Proc Natl Acad Sci U S A (1978) 1.28

Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol Pharmacol (1994) 1.27

Proteolytic nicking of the acetylcholine receptor. Biochemistry (1980) 1.25

Monoclonal antibodies as probes of acetylcholine receptor structure. 2. Binding to native receptor. Biochemistry (1981) 1.24

Monoclonal antibodies as probes of acetylcholine receptor structure. 1. Peptide mapping. Biochemistry (1981) 1.23

Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol (1997) 1.21

Homomeric and native alpha 7 acetylcholine receptors exhibit remarkably similar but non-identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex. FEBS Lett (1993) 1.20

Immunochemical similarities between subunits of acetylcholine receptors from Torpedo, Electrophorus, and mammalian muscle. Biochemistry (1979) 1.20

Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome. Annu Rev Immunol (1985) 1.19

Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity. J Neuroimmunol (1986) 1.19

Acetylcholine receptor in planar lipid bilayers. Characterization of the channel properties of the purified nicotinic acetylcholine receptor from Torpedo californica reconstituted in planar lipid bilayers. J Gen Physiol (1984) 1.18

Location of antigenic determinants on primary sequences of subunits of nicotinic acetylcholine receptor by peptide mapping. Biochemistry (1986) 1.18

"Orphan" alpha6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. Mol Pharmacol (1997) 1.17

Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. J Exp Med (1995) 1.17

Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors. J Pharmacol Exp Ther (1998) 1.16

Alternative splicing generates two isoforms of the alpha 2 subunit of the inhibitory glycine receptor. FEBS Lett (1991) 1.15

Inhibition of glucose trimming with castanospermine reduces calnexin association and promotes proteasome degradation of the alpha-subunit of the nicotinic acetylcholine receptor. J Biol Chem (1998) 1.15

Functional properties of human nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of alpha3beta4 AChRs expressed in permanently transfected HEK cells. J Gen Physiol (2001) 1.14

Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system. J Neurosci (1987) 1.14

Spatiotemporal patterns of activity in an intact mammalian network with single-cell resolution: optical studies of nicotinic activity in an enteric plexus. J Neurosci (1999) 1.12

Single channel properties of human alpha3 AChRs: impact of beta2, beta4 and alpha5 subunits. J Physiol (1999) 1.12

Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera. Nature (1978) 1.08

cDNA clones coding for the structural subunit of a chicken brain nicotinic acetylcholine receptor. Neuron (1988) 1.08

Acquired myasthenia gravis. Selective involvement of esophageal, pharyngeal, and facial muscles. J Vet Intern Med (1991) 1.07

The acetylcholine receptor channel from Torpedo californica has two open states. J Neurosci (1984) 1.06

Immunochemical tests of acetylcholine receptor subunit models. Nature (1984) 1.06

Functional equivalence of monomeric and dimeric forms of purified acetylcholine receptors from Torpedo californica in reconstituted lipid vesicles. Eur J Biochem (1980) 1.05

Adjacent basic amino acid residues recognized by the COP I complex and ubiquitination govern endoplasmic reticulum to cell surface trafficking of the nicotinic acetylcholine receptor alpha-Subunit. J Biol Chem (2001) 1.05

The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor. Cloning of the alpha-subunit cDNA. FEBS Lett (1988) 1.05

Optical studies of nicotinic acetylcholine receptor subtypes in the guinea-pig enteric nervous system. J Exp Biol (2005) 1.05

Neuronal nicotinic acetylcholine receptor beta-subunit is coded for by the cDNA clone alpha 4. FEBS Lett (1987) 1.05

Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol Pharmacol (1991) 1.05

Evidence that the acetylcholine binding site is not formed by the sequence alpha 127-143 of the acetylcholine receptor. Biochemistry (1986) 1.05

Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera. J Clin Invest (1992) 1.04

Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis. Tissue Antigens (1978) 1.03

Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Res Mol Brain Res (2000) 1.02

cDNA clone for the alpha subunit of the acetylcholine receptor from the mouse muscle cell line BC3H-1. Proc Natl Acad Sci U S A (1983) 1.02

Reduced muscle acetylcholine sensitivity in rats immunised with acetylcholine receptor. Nature (1976) 1.02

Immunohistochemical localization of monoclonal antibodies to the nicotinic acetylcholine receptor in chick midbrain. Proc Natl Acad Sci U S A (1983) 1.02

Fibroblast growth factor: its localization, purification, mode of action, and physiological significance. Adv Metab Disord (1975) 1.02

Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum. Neuroscience (2002) 1.01

Three subtypes of alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina. J Neurosci (1993) 1.01

Water-soluble nicotinic acetylcholine receptor formed by alpha7 subunit extracellular domains. J Biol Chem (1998) 0.99

Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis. Muscle Nerve (1980) 0.99

Synthetic peptides used to locate the alpha-bungarotoxin binding site and immunogenic regions on alpha subunits of the nicotinic acetylcholine receptor. Biochemistry (1987) 0.99

Biology of myasthenia gravis. Annu Rev Pharmacol Toxicol (1980) 0.99

Incorporation of acetylcholine receptors into liposomes. Vesicle structure and acetylcholine receptor function. J Biol Chem (1982) 0.97

The regulation of acetylcholine receptor expression in mammalian muscle. Cold Spring Harb Symp Quant Biol (1983) 0.97